Ichilov Tech

Ichilov Tech is the innovation and investment arm of the Tel Aviv Sourasky Medical Center, also known as Ichilov, with a focus on partnering with deep-tech founders to embed applied AI directly into clinical care. The hospital integration is the structural advantage: Ichilov Tech operates inside one of Israel’s largest medical centers, giving portfolio companies access to clinicians, patient data, and clinical-validation environments that would otherwise take years to build.

The thesis is concentrated on digital health, AI in healthcare, and medical devices that can be co-developed with Ichilov clinicians and then exported to other healthcare systems. The fund is comfortable with companies that need real clinical engagement to develop their products, and it operates with a hands-on model that resembles a hospital innovation program more than a traditional financial investor. The portfolio is not deeply public, but the operating pattern is consistent across the engagement model.

Check sizes sit in the 250 thousand to 1 million dollar range, consistent with the pre-seed and seed positioning. Stage focus is firmly at the start: pre-seed and seed, with the expectation that follow-on capital will come from Israeli healthtech-specialist funds and international Series A investors. Geography is Israel-anchored, with the hospital network providing the initial validation environment and the broader Israeli healthtech ecosystem providing the commercial pathways.

The team is built around clinicians, innovation operators, and technologists embedded inside the hospital, with deep institutional knowledge of clinical workflow and patient-data structures. Diligence is built around the clinical-fit value proposition.

Approach Ichilov Tech when you are a physician or technical founder with a clinical AI tool or medical-device product that genuinely needs deep hospital engagement to develop. Pure software companies without a clinical-integration angle will be a worse fit, as will companies that already have established clinical-validation environments and just need capital. The most direct path in is through Ichilov clinicians, the hospital’s innovation programs, or the Ichilov Tech office directly. Time the conversation when you have a research insight or early product idea, a willingness to co-develop with clinicians, and the institutional flexibility to operate inside a hospital environment. Pre-Series A founders are the right fit; later-stage companies will find a better home elsewhere.